Jacobio's self-developed global first-in-class drug Aurora A inhibitor JAB-2485 received IND (Investigational New Drug) from the FDA (Food and Drug Administration) in US. Jacobio...
Lightsense Technology, a pioneer in developing multi-spectroscopic solutions to address critical problems in public health—from the opioid crisis to the Covid-19 pandemic, as well...
On January 13, 2022, Green Valley (Shanghai) Pharmaceuticals Co., Ltd. received the letter from the US Food and Drug Administration (FDA) on the Investigational...
Graphite Health, a member-led company intent on transforming digital health care to improve patient outcomes and lower costs, announced today that Kaiser Permanente is...
Mitsubishi Tanabe Pharma America, Inc. (MTPA) announced the U.S. Food and Drug Administration (FDA) has accepted the new drug application (NDA) for an investigational...
